Back to Search Start Over

The db mutation improves memory in younger mice in a model of Alzheimer's disease.

Authors :
Zhang, Le
Fernandez-Kim, Sun-Ok
Beckett, Tina L.
Niedowicz, Dana M.
Kohler, Katharina
Dasuri, Kalavathi
Bruce-Keller, Annadora J.
Murphy, M. Paul
Keller, Jeffrey N.
Source :
BBA: Molecular Basis of Disease. Sep2019, Vol. 1865 Issue 9, p2157-2167. 11p.
Publication Year :
2019

Abstract

Alzheimer's disease (AD) is the most common age-related neurodegenerative disease, while obesity is a major global public health problem associated with the metabolic disorder type 2 diabetes mellitus (T2DM). Chronic obesity and T2DM have been identified as invariant risk factors for dementia and late-onset AD, while their impacts on the occurrence and development of AD remain unclear. As shown in our previous study, the diabetic mutation (db, Lepr db/db ) induces mixed or vascular dementia in mature to middle-aged APP ΔNL/ΔNL x PS1 P264L/P264L knock-in mice (db/AD). In the present study, the impacts of the db mutation on young AD mice at 10 weeks of age were evaluated. The db mutation not only conferred young AD mice with severe obesity, impaired glucose regulation and activated mammalian target of rapamycin (mTOR) signaling pathway in the mouse cortex, but lead to a surprising improvement in memory. At this young age, mice also had decreased cerebral Aβ content, which we have not observed at older ages. This was unlikely to be related to altered Aβ synthesis, as both β- and γ-secretase were unchanged. The db mutation also reduced the cortical IL-1β mRNA level and IBA1 protein level in young AD mice, with no significant effect on the activation of microglia and astrocytes. We conclude that the db mutation could transitorily improve the memory of young AD mice, a finding that may be partially explained by the relatively improved glucose homeostasis in the brains of db/AD mice compared to their counterpart AD mice, suggesting that glucose regulation could be a strategy for prevention and treatment of neurodegenerative diseases like AD. • db mutation caused obesity and metabolic disturbances in 10-week-old AD mice. • db mutation improved memory, decreased cerebral Aβ content of the young AD mice. • db mutation unlikely alter Aβ synthesis and tau pathology in the young AD mice. • db mutation is not associated with neuroinflammation in the young AD mice. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09254439
Volume :
1865
Issue :
9
Database :
Academic Search Index
Journal :
BBA: Molecular Basis of Disease
Publication Type :
Academic Journal
Accession number :
137324029
Full Text :
https://doi.org/10.1016/j.bbadis.2019.04.013